🔗 Share this article

Chancellor Reeves has stated she is preparing "focused steps to address household expense pressures" in next month's Budget.

In comments to the BBC, she stated that curbing price rises is a collective task of both the administration and the Bank of England.

The UK's price growth is projected to be the most elevated among the Group of Seven industrialized countries this calendar year and next.

Possible Utility Cost Measures

Reports indicate the government could take action to reduce energy bills, such as by cutting the current 5% level of value-added tax applied on energy.

An additional possibility is to reduce some of the government charges presently included in household expenses.

Budgetary Limitations and Analyst Expectations

The government will obtain the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much room there is for such actions.

The view from the majority of economists is that the Chancellor will have to introduce tax rises or budget cuts in order to meet her voluntary borrowing rules.

Earlier on the same day, estimates showed there was a £22bn deficit for the Treasury chief to fill, which is at the lower end of forecasts.

"There's a joint responsibility between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor stated to the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and International Concerns

While a great deal of the attention has been on likely tax increases, the chancellor said the most recent data from the OBR had not altered her pledge to campaign commitments not to raise rates on income tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with increasing geopolitical and trade concerns for the fiscal revenue measures, probably to be directed on those "wealthiest."

International Trade Disputes

Commenting on concerns about the UK's commercial links with China she said: "Our national security invariably are paramount."

Last week's statement by China to strengthen export controls on rare earths and other materials that are crucial for advanced tech production led American leader Donald Trump to threaten an further 100% import tax on imports from the Asian country, increasing the possibility of an full-scale trade war between the two economic giants.

The US Treasury Secretary described China's move "economic coercion" and "a global supply chain power grab."

Asked about considering the US offer to participate in its conflict with China, the Chancellor said she was "extremely troubled" by Chinese measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "damaging for the global economy and generates additional headwinds."

"It is my opinion there are areas where we should address China, but there are also significant opportunities to export to Chinese markets, including banking sector and other sectors of the economic system. We've got to get that balance appropriate."

The chancellor also stated she was working with international partners "regarding our own essential resources approach, so that we are less reliant."

Health Service Drug Pricing and Funding

The Chancellor also acknowledged that the price the National Health Service spends on drugs could go up as a consequence of current talks with the US government and its pharmaceutical firms, in exchange for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or scrapping investments in the UK, with some attributing the insufficient payments they are obtaining.

Last month, the government science advisor said the cost the health service pays for medicines would must rise to halt firms and drug research funding leaving the UK.

Reeves told media: "We have seen as a result of the pricing regime, that clinical trials, innovative medicines have not been provided in the United Kingdom in the way that they are in other European countries."

"Our aim is to guarantee that people receiving treatment from the NHS are can access the best critical medicines in the globe. And so we are examining this situation, and... seeking to obtain increased capital into the UK."